The Prescription Information Modernization Act of 2026 aims to modernize how prescribing information for drugs, including biological products, is communicated. The main objective is to allow this information to be shared primarily through digital means, making it more accessible and efficient for healthcare providers. Key provisions of the Act include the amendment of existing laws to permit manufacturers to provide required prescribing information electronically.